Clinical characteristics, treatment patterns and outcomes of patients older than 80  years diagnosed with DLBCL in China over a 10-year period

ConclusionsHigh response rate was concluded on very elderly DLBCL patients ( ≥ 80 years old) with reduced-dose R-CHOP. However, the very elderly patients with NCCN-IPI score ≥ 5 would lead to poor outcome.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research